FNB vs MTG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
FNB presents a stark contrast between deep value and deteriorating financial health, highlighted by a weak Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($26.4) and Intrinsic Value ($47.79), and trades below book value (P/B 0.92), the deterministic health markers are concerning. Strong YoY earnings growth (18.8%) and a consistent track record of earnings beats provide a bullish fundamental backdrop, but these are offset by bearish insider sentiment and a complete lack of technical momentum. The overall outlook is neutral as the value proposition is currently fighting against poor operational health signals.
MTG presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a significant valuation discount, trading at $29.13 against a Graham Number of $40.72 and an Intrinsic Value of $40.35. The company exhibits exceptional operational efficiency with a 60.84% profit margin and a rock-solid balance sheet (Debt/Equity of 0.13). While revenue growth is stagnant and insider sentiment is bearish, the consistent track record of earnings beats over 25 quarters suggests a highly disciplined management team. The bullish outlook is driven by the massive margin of safety provided by the current price relative to defensive fair value.
Compare Another Pair
Related Comparisons
FNB vs MTG: Head-to-Head Comparison
This page compares F.N.B. Corporation (FNB) and MGIC Investment Corporation (MTG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.